CD40LG and atherosclerosis: In experimental atherosclerosis models, peptide-mediated disruption of Mac-1-CD40L reduced lesion size, limited macrophage and lesion lipid content and increased collagen content in the aortic root, reflecting a clinically favourable stable plaque, without compromising immunity or thrombosis [32].